- Is pancreatitis a genetic disease?
Is pancreatitis a genetic disease?
CentoWebinar - "Pancreatitis - a genetic disease?"
Pancreatitis is a common cause of abdominal symptoms and pain. If diagnosed, especially in the young, the question as to the etiology arises.
Watch our guest speaker, Prof. Matthias Löhr, Professor of Gastroenterology & Hepatology at Karolinska Institutet and Prof. Peter Bauer as they examine how genetic markers can indicate different mechanisms and different consequences for patients with pancreatitis, and how this can indicate for example a significantly increased risk to develop pancreatic cancer.
In addition, learn how several rare diseases have pancreatic affections that can be diagnosed.
- Physiological role of the pancreas
- The genes involved in "hereditary" pancreatitis
- Rare diseases
- How to apply genetic testing
Matthias Löhr, Prof. of Gastroenterology & Hepatology at Karolinska Institutet
Matthias Löhr was appointed Professor of gastroenterology & hepatology at Karolinska Institutet in 2007, incoming from the Univ. Heidelberg/dkfz. From the time of his MD thesis through PhD and later, he concentrated on several aspects of the pancreas, both in clinical medicine, translational and basic sciences. He is heading the Pancreas Research Team at Gastrocentrum and leading the KICancer Diagnose-related network for HPB tumors. For the European Gastroenterologists (UEG), he is sitting in several committees at the EU in Brussels. He is also leading the Pancreas 2000 program, an educational program for future Pancreatologists in Europe.
Peter Bauer, CSO of CENTOGENE
Peter Bauer received his board certification in Human Genetics in 2006 and headed the molecular diagnostic laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Moreover, he is Vice President of the German Society of Neurogenetics (DGNG). Peter has authored more than 140 publications in neurogenetics, oncogenetics, cardiogenetics and sequencing technology and is leading author of the ‘Guidelines for diagnostic next-generation sequencing’.